Community Research and Development Information Service - CORDIS

Results 1 - 10 of 328
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Nanoelectronics for Mobile AAL Systems
ID: 120228
Start date: 2010-04-01, End date: 2013-03-01
The ENIAC JU project MAS is developing nanoelectronics components for applications in the field of health and wellness, and to create a development platform for the design of complete flexible, robust and safe mobile ambient-assisted-living systems. The project covers remote ...
Programme: FP7-JTI
Record Number: 201992
Last updated on: 2017-05-25
Smart Power Management in Home and Health
ID: 120008
Start date: 2009-02-01, End date: 2012-01-01
According to studies, worldwide energy consumption is rising dramatically and will double in the next 20 years and with it CO2 emission. The consequence will be an escalating price for energy and upcoming challenges for ensuring Europe´s energy supply. Reducing Energy Consump...
Programme: FP7-JTI
Record Number: 201933
Last updated on: 2017-05-25
Implementing Manufacturing science solutions to increase equipment PrOductiVity and fab pErformance
ID: 120005
Start date: 2009-03-01, End date: 2012-02-01
IMPROVE aims to improve European Semiconductor fabs efficiency by providing methods and tools to better control the process variability, reduce the cycle time and enhance the effectiveness of the production equipment. This will be achieved thanks to 3 major developments. The ...
Programme: FP7-JTI
Record Number: 210744
Last updated on: 2017-05-25
E3Car -> Nanoelectronics for an energy efficient electrical car
ID: 120001
Start date: 2009-02-01, End date: 2012-01-01
The objective of the project is the development of nanoelectronics technologies, devices, circuits architectures and modules for electrical cars/vehicles and demonstration of these modules in a final systems. Emissions from road vehicles have to be reduced substantially in th...
Programme: FP7-JTI
Record Number: 201988
Last updated on: 2017-05-25
Applied Public-Private Research enabling OsteoArthritis Clinical Headway
ID: 115770
Start date: 2015-06-01, End date: 2020-11-30
The problem: finding the right patient for the right treatment Despite a large and growing disease burden in osteoarthritis (OA), many pharmaceutical companies have de-emphasized or even abandoned OA drug development due to perceived hurdles. Crucial in this is the lack of ap...
Programme: FP7-JTI
Record Number: 203727
Last updated on: 2017-05-25
Zoonotic Anticipation and Preparedness Initiative
ID: 115760
Start date: 2015-03-01, End date: 2020-02-29
Emerging infectious diseases are occurring at increasing frequency in Europe and other regions of the world, having profound impacts on public and/or veterinary health as well as disruptive effects on sector, regional or even global economy. The predominantly zoonotic nature ...
Programme: FP7-JTI
Record Number: 203726
Last updated on: 2017-05-25
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
ID: 115749
Start date: 2015-01-01, End date: 2019-12-31
Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential to improve the development of personalized medicines for cancer patients. This is of particular importance when biopsies of the primary ...
Programme: FP7-JTI
Record Number: 203725
Last updated on: 2017-05-25
Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections
ID: 115737
Start date: 2015-01-01, End date: 2021-12-31
Antimicrobial resistance (AMR) is a major global public health threat, and most troublesome is the rapid emergence and dissemination of multidrug resistant (MDR) Enterobacteriaceae, Acinetobacter species and Pseudomonas aeruginosa. There is an unmet medical need to prevent P....
Programme: FP7-JTI
Record Number: 203724
Last updated on: 2017-05-25
Intelligent Assessment of Pharmaceutical in the Environment
ID: 115735
Start date: 2015-01-01, End date: 2018-12-31
Active pharmaceutical ingredients (APIs) can be released to the natural environment during the manufacturing process, following use by patients or when unused medicines are disposed of. As APIs are biologically active compounds concerns have been raised about the potential ef...
Programme: FP7-JTI
Record Number: 203722
Last updated on: 2017-05-25
iABC Programme
[PROJECT] IABC PROGRAMME - iABC Programme
ID: 115721
Start date: 2015-08-01, End date: 2020-07-31
Cystic Fibrosis (CF) is a common fatal inherited disease with a frequency of 1 in 2500 live births, affecting approximately 36,000 (0.737/10,000) people in the EU. Chronic bacterial pulmonary infection leading to an irreversible decline in lung structure and function is the m...
Programme: FP7-JTI
Record Number: 203721
Last updated on: 2017-05-25
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2017-05-26
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top